Geode Capital Management
SPPI

Geode Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Geode Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,783,701
Closed -$1.71M – 4865
2023
Q2 		$1.71M Buy
1,783,701
+26,264
+1% +$26K ﹤0.01% 3160
2023
Q1 		$1.32M Buy
1,757,437
+245,235
+16% +$179K ﹤0.01% 3224
2022
Q4 		$557K Sell
1,512,202
-39,550
-3% -$16.7K ﹤0.01% 3620
2022
Q3 		$667K Sell
1,551,752
-183,973
-11% -$181K ﹤0.01% 3581
2022
Q2 		$1.35M Sell
1,735,725
-991,807
-36% -$874K ﹤0.01% 3281
2022
Q1 		$3.52M Buy
2,727,532
+203,897
+8% +$188K ﹤0.01% 2978
2021
Q4 		$3.21M Sell
2,523,635
-162,898
-6% -$291K ﹤0.01% 3137
2021
Q3 		$5.86M Buy
2,686,533
+39,268
+1% +$107K ﹤0.01% 2814
2021
Q2 		$9.93M Buy
2,647,265
+244,021
+10% +$848K ﹤0.01% 2465
2021
Q1 		$7.83M Buy
2,403,244
+216,544
+10% +$776K ﹤0.01% 2521
2020
Q4 		$7.46M Buy
2,186,700
+209,358
+11% +$862K ﹤0.01% 2357
2020
Q3 		$8.07M Buy
1,977,342
+307,232
+18% +$1.17M ﹤0.01% 2096
2020
Q2 		$5.64M Buy
1,670,110
+70,034
+4% +$204K ﹤0.01% 2267
2020
Q1 		$3.73M Buy
1,600,076
+58,649
+4% +$161K ﹤0.01% 2310
2019
Q4 		$5.61M Buy
1,541,427
+70,544
+5% +$570K ﹤0.01% 2386
2019
Q3 		$12.2M Buy
1,470,883
+57,310
+4% +$464K ﹤0.01% 1802
2019
Q2 		$12.2M Buy
1,413,573
+136,312
+11% +$1.22M ﹤0.01% 1798
2019
Q1 		$13.7M Buy
1,277,261
+121,142
+10% +$1.3M ﹤0.01% 1686
2018
Q4 		$10.1M Buy
1,156,119
+130,715
+13% +$1.66M ﹤0.01% 1781
2018
Q3 		$17.2M Buy
1,025,404
+56,868
+6% +$1.23M ﹤0.01% 1516
2018
Q2 		$20.3M Buy
968,536
+139,893
+17% +$2.59M 0.01% 1345
2018
Q1 		$13.3M Buy
828,643
+16,796
+2% +$333K ﹤0.01% 1553
2017
Q4 		$15.4M Buy
811,847
+157,130
+24% +$2.85M 0.01% 1456
2017
Q3 		$9.21M Buy
654,717
+57,160
+10% +$517K ﹤0.01% 1791
2017
Q2 		$4.45M Buy
597,557
+52,439
+10% +$343K ﹤0.01% 2232
2017
Q1 		$3.54M Buy
545,118
+30,649
+6% +$171K ﹤0.01% 2320
2016
Q4 		$2.28M Buy
514,469
+30,562
+6% +$128K ﹤0.01% 2559
2016
Q3 		$2.26M Buy
483,907
+83,594
+21% +$495K ﹤0.01% 2488
2016
Q2 		$2.63M Buy
400,313
+6,614
+2% +$46.7K ﹤0.01% 2299
2016
Q1 		$2.5K Buy
393,699
+3,699
+0.9% +$19K ﹤0.01% 2305
2015
Q4 		$2.35M Buy
390,000
+8,505
+2% +$48.6K ﹤0.01% 2364
2015
Q3 		$2.28M Buy
381,495
+2,439
+0.6% +$16.9K ﹤0.01% 2360
2015
Q2 		$2.59M Buy
379,056
+33,099
+10% +$210K ﹤0.01% 2332
2015
Q1 		$2.1M Buy
345,957
+14,289
+4% +$95.1K ﹤0.01% 2408
2014
Q4 		$2.3M Buy
331,668
+34,158
+11% +$251K ﹤0.01% 2339
2014
Q3 		$2.42M Buy
297,510
+6,007
+2% +$47K ﹤0.01% 2251
2014
Q2 		$2.37M Buy
291,503
+6,079
+2% +$46.1K ﹤0.01% 2269
2014
Q1 		$2.24M Buy
285,424
+10,063
+4% +$85.2K ﹤0.01% 2270
2013
Q4 		$2.44M Buy
275,361
+5,867
+2% +$52.4K ﹤0.01% 2172
2013
Q3 		$2.26M Buy
269,494
+53,087
+25% +$430K ﹤0.01% 2099
2013
Q2 		$1.61M Buy
+216,407
New +$1.66M ﹤0.01% 2167

Geode Capital Management's SPPI Position: Q3 2023 in Review

Geode Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 1,783,701 shares — an estimated $1.71M sold.

Geode Capital Management first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $20.3M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Geode Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Geode Capital Management sold 1,783,701 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $1.71M.
  • Geode Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
  • Geode Capital Management's Spectrum Pharmaceuticals Inc position peaked at $20.3M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.